Troy Edward Wilson
President and CEO at Kura Oncology Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Kura Oncology Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Puma Biotechnology Inc June 11, 202685.8%
-
Puma Biotechnology Inc June 11, 202569.4%
-
Puma Biotechnology Inc June 18, 202478.4%
-
Kura Oncology Inc. June 5, 202488.5%
-
Puma Biotechnology Inc June 13, 202387.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Puma Biotechnology Inc | Open-market sale | −5,000 | $9.10 | $45,500 |
| Aug 24, 2026 | Kura Oncology Inc. | Open-market purchase | +100,000 | $12.39 | $1,239,000 |
| Aug 17, 2026 | Kura Oncology Inc. | Open-market purchase | +100,000 | $11.12 | $1,112,000 |
| Jun 12, 2026 | Puma Biotechnology Inc | Open-market sale | −10,800 | $7.20 | $77,760 |
| Jun 11, 2026 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Mar 23, 2026 | Kura Oncology Inc. | Option exercise | +6,103 | $6.15 | $37,533 |
| Nov 13, 2025 | Kura Oncology Inc. | Grant or award | +182,500 | — | — |
| Sep 29, 2025 | Kura Oncology Inc. | Open-market sale | −36,615 | $8.94 | $327,338 |
| Sep 27, 2025 | Kura Oncology Inc. | Grant or award | +182,500 | — | — |
| Sep 8, 2025 | Kura Oncology Inc. | Open-market purchase | +50,000 | $8.20 | $410,000 |
| Aug 13, 2025 | Kura Oncology Inc. | Open-market purchase | +13,494 | $6.64 | $89,600 |
| Aug 12, 2025 | Kura Oncology Inc. | Open-market purchase | +36,506 | $5.85 | $213,560 |
| Jun 13, 2025 | Puma Biotechnology Inc | Open-market sale | −10,800 | $3.40 | $36,720 |
| Jun 11, 2025 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Jun 18, 2024 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
Questions about Troy Edward Wilson
What boards is Troy Edward Wilson on?
Troy Edward Wilson sits on the boards of Atrium Therapeutics Inc., Kura Oncology Inc. and Puma Biotechnology Inc.
What company is Troy Edward Wilson the CEO of?
Troy Edward Wilson is President and CEO of Kura Oncology Inc.
How long has Troy Edward Wilson served on boards?
Our records show at least 8 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.